SynthesisMedicine2016

Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis of 10 Randomized Controlled Trials.

Yong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.